Aflibercept may be beneficial for AMD Aflibercept 2.0 mg may be beneficial for cases of exudative AMD unsuccessfully treated with ranibizumab or bevacizumab, according to a recent retrospective review. More...
PIOL suitable for myopic eyes The acrylic angle-supported phakic IOL (PIOL) provides moderate one-year rotational stability, making it a successful treatment option for myopic eyes, claims a new paper. More...